All IDC research is © 2015 by IDC. All rights reserved. All IDC materials are licensed with IDC's permission and in no way does the use or publication of IDC research indicate IDC's endorsement of Dassault Système’s products/or strategies. AN IDC INFOGRAPHIC, SPONSORED BY DASSAULT SYSTÈMES Life Sciences Research Challenges Facing the Research Ecosystem Life Sciences Industry Goals Why Biologics is Increasingly Important BIOVIA Biologics for Discovery, Development and Manufacturing The R&D ecosystem is becoming increasingly complex It’s getting harder to: Quality 51% Efficiency Innovation Reduce variability in processes and products; quality by design for better process understanding Harmonization, standardization, integration, externalization Global collaboration, new technologies, knowledge management, shift toward biologics Reasons for growth: Users report up to 50% gains in efficiency and throughput, as well as improved quality of results with this type of solution. Learn more about challenges facing biologics discovery researchers and product developers, and Dassault Systèmes' BIOVIA Biologics solution, by downloading the IDC white paper, "Looking Forward: The Case for Intelligent Design (and Infrastructure) in Life Science Biologics R&D.” Intelligent Infrastructure for Access new research capabilities Work well with global teams Pick the right tool for the right task Visualize and share complex models Standardize experimentation Share and transfer data internally and externally Leverage rapid growth of data, information, and knowledge Superior efficacy Premium pricing 12-year exclusivity (U.S.) Satisfies previously unmet clinical needs Discovery and Analysis Registration and Sample Management Predictive Analytics Process Production Operations Workflow Support Regulatory Quality Compliance Bioprocess Documentation and Data Management BIOVIA FOUNDATION of the top 100 prescription and OTC drug sales will be biologics by 2018* *EvaluatePharma 6 of the top-selling drugs in 2014 were biologics*